This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Information about Jacobsen Distal 11q Deletion Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Most recent studies have shown that Jacobsen Distal 11q Deletion Syndrome shares some biological mechanisms with chromosomal-deletion, chromosome-fragility, congenital-abnormality, congenital-anomaly-of-face, congenital-heart-defects, craniofacial-abnormalities, cytogenetic-abnormality, developmental-delay-(disorder), dwarfism, heart-diseases, infective-disorder, loss-of-chromosome-11, monosomy, pancytopenia, psychomotor-disorders, trigonocephaly, trisomy.
Among the many pathways, these few ones have gauged particular interests from scientists studying Jacobsen Distal 11q Deletion Syndrome, and have been seen in publications frequently: Cell Adhesion, Chromosome Breakage, Dna Replication, Eye Development, Eye Morphogenesis, Forebrain Development, Heart Development, Hemopoiesis, Interphase, Localization, Locomotory Behavior, Megakaryocyte Differentiation, Methylation, Mitosis, Myelination, Nervous System Development, Nucleosome Assembly, Organ Development, Pathogenesis, System Development
Quite a number of genes have been found to play important roles in Jacobsen Distal 11q Deletion Syndrome, such as ACAT1, AFF2, CBL, ETS1, FLI1, FLII, FMR1, JAK3, JAM3, MB, MYH10, NCAM1, RUNX1, SLC25A5, TECTA, TYRO3, UBR1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.